Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Takeda UK Ltd
Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH
Telephone: +44 (0)1628 537 900
Fax: +44 (0)1628 526 615
WWW: http://www.Takeda.co.uk
Medical Information Direct Line: +44 (0)1628 537 900
Medical Information e-mail: medinfo@takeda.co.uk
Medical Information Fax: +44 (0)1628 526 617

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 07/03/2011
SPC Mepact 4 mg powder for suspension for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   05-Jan-2011
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company
In section 6.3, the shelf-life has been changed from 2 years to 3months
Updated on 13/05/2010 and displayed until 07/03/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Date of revision of text on the SPC:   28-Feb-2010
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company


7.         MARKETING AUTHORISATION HOLDER

 

IDM PHARMA SAS

11-15 Quai De Dion Bouton

92816 Puteaux Cedex

France

 

 
Updated on 10/02/2010 and displayed until 13/05/2010
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company
None provided

Active Ingredients/Generics

 
  mifamurtide